EMAIL THIS PAGE TO A FRIEND

Nature

SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.


PMID 24909994

Abstract

Cancer stem cells (CSCs) have been reported in various cancers, including in skin squamous-cell carcinoma (SCC). The molecular mechanisms regulating tumour initiation and stemness are still poorly characterized. Here we find that Sox2, a transcription factor expressed in various types of embryonic and adult stem cells, was the most upregulated transcription factor in the CSCs of squamous skin tumours in mice. SOX2 is absent in normal epidermis but begins to be expressed in the vast majority of mouse and human pre-neoplastic skin tumours, and continues to be expressed in a heterogeneous manner in invasive mouse and human SCCs. In contrast to other SCCs, in which SOX2 is frequently genetically amplified, the expression of SOX2 in mouse and human skin SCCs is transcriptionally regulated. Conditional deletion of Sox2 in the mouse epidermis markedly decreases skin tumour formation after chemical-induced carcinogenesis. Using green fluorescent protein (GFP) as a reporter of Sox2 transcriptional expression (SOX2-GFP knock-in mice), we showed that SOX2-expressing cells in invasive SCC are greatly enriched in tumour-propagating cells, which further increase upon serial transplantations. Lineage ablation of SOX2-expressing cells within primary benign and malignant SCCs leads to tumour regression, consistent with the critical role of SOX2-expressing cells in tumour maintenance. Conditional Sox2 deletion in pre-existing skin papilloma and SCC leads to tumour regression and decreases the ability of cancer cells to be propagated upon transplantation into immunodeficient mice, supporting the essential role of SOX2 in regulating CSC functions. Transcriptional profiling of SOX2-GFP-expressing CSCs and of tumour epithelial cells upon Sox2 deletion uncovered a gene network regulated by SOX2 in primary tumour cells in vivo. Chromatin immunoprecipitation identified several direct SOX2 target genes controlling tumour stemness, survival, proliferation, adhesion, invasion and paraneoplastic syndrome. We demonstrate that SOX2, by marking and regulating the functions of skin tumour-initiating cells and CSCs, establishes a continuum between tumour initiation and progression in primary skin tumours.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

D27802
1,4-Diazabicyclo[2.2.2]octane, ReagentPlus®, ≥99%
C6H12N2
SAB1405571
Anti-CCND2 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA049138
Anti-CCND2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1411587
Anti-CCND2 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
GW10811F Anti-CD34 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB4300690
Anti-CD34 antibody produced in rabbit, affinity isolated antibody
SAB1405515
Anti-CEACAM1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2501316
Anti-HMGA2 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB4300681
Anti-HMGA2 antibody produced in rabbit, affinity isolated antibody
SAB2701959
Anti-HMGA2 antibody produced in rabbit
SAB2500531
Anti-IGF2BP2 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2104501
Anti-IGF2BP2 antibody produced in rabbit, affinity isolated antibody
HPA035145
Anti-IGF2BP2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1100194
Anti-ITGA3 (1037-1051) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
GW21339 Anti-ITGA3 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
HPA008572
Anti-ITGA3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4501656
Anti-Keratin 10 antibody produced in rabbit, affinity isolated antibody
AV41730
Anti-KRT10 antibody produced in rabbit, affinity isolated antibody
HPA012014
Anti-KRT10 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1409273
Anti-KRT14 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
AV15002 Anti-KRT14 antibody produced in rabbit, IgG fraction of antiserum
HPA023040
Anti-KRT14 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1410741
Anti-KRT14 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB2501272
Anti-PDPN antibody produced in goat, affinity isolated antibody, buffered aqueous solution
HPA007534
Anti-PDPN antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV44528
Anti-PDPN antibody produced in rabbit, affinity isolated antibody
SAB2101763
Anti-PDPN antibody produced in rabbit, affinity isolated antibody
SAB1306180 ANTI-PHOSPHO-H3(S10) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1306179 ANTI-PHOSPHO-H3(S10) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1305681 ANTI-PHOSPHO-H3(S28) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution